有關截至二零二四年⼗二⽉三⼗⼀⽇⽌年度年報 持續經營和緩解措施之更新資料 香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示概不就因本公佈全部或任何部份內容而產生或因倚賴 該等內容而引致之任何損失承擔任何責任。 玖 源 化 工（ 集 團 ）有 限 公 司 Ko Yo Chemical (Group) Limited （於開曼群島註冊成立之有限公司） （股份代號：00827） 內幕消息 本公司股東及有意投資者於買賣本公司股份時務請審慎行事。 承董事會命 玖源化工（集團）有限公司 主席 湯國強 香港，二零二六年三月三十一日 於本公佈日期，董事會包括三位執行董事，為湯國強先生、張偉華先生及范超先 生及三位獨立非執行董事徐從才先生、樂宜仁先生及魯藝女士。 本公佈乃由玖源化工（集團）有限公司（「本公司」，連同其附屬公司統稱「本集 團」）根據香港聯合交易所有限公司證券上市規則（「上市規則」）第13.09條及證 券及期貨條例（香港法例第571章）第XIVA部之內幕消息條文（定義見上市規則）而 作出。 茲提述本公司截至二零二四年十二月三十一日止年度之年報（ ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2026年3月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 玖源化工(集團)有限公司 呈交日期: 2026年3月31日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00827 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 20,000,000,000 | HKD | | 0.1 | HKD | | 2,000,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 20,000,000,000 | HKD | | 0.1 | HKD | | 2,000,000,000 | 本 ...

Financial Performance - For the fiscal year ending December 31, 2025, the company reported a loss attributable to owners of approximately RMB 747 million, an increase of RMB 242 million compared to a loss of RMB 505 million in 2024[2]. - Basic loss per share for the fiscal year was approximately RMB 0.1213[2]. - Total revenue for the fiscal year was approximately RMB 2,162 million, representing a decrease of about 16.8% compared to 2024[2]. - The company reported a net loss of RMB 747,180,000 for the year 2025, compared to a loss of RMB 505,395,000 in 2024, indicating an increase in losses of approximately 47.7% year-over-year[31]. - The gross margin decreased from approximately 1.3% in 2024 to -3.0% in 2025, primarily due to a decline in product prices[74]. - The company recorded a revenue of approximately RMB 2,162,000,000, a decrease of 16.8% compared to the previous year, primarily due to lower product prices[73]. - The company's attributable loss was approximately RMB 747,000,000, an increase in loss of about RMB 242,000,000 compared to the previous year, with a basic loss per share of approximately RMB 0.1213[73]. Revenue Breakdown - Revenue from major products for 2025 included: Urea at RMB 671,533,000, Ammonia at RMB 618,163,000, and Methanol at RMB 870,884,000, totaling RMB 2,161,891,000, a decrease from RMB 2,599,733,000 in 2024[18]. - Sales of urea amounted to RMB 671.5 million, down 9.5%, while sales volume increased by 7.4%[3]. - Sales of ammonia decreased by 27.2% to RMB 618.2 million, with a sales volume drop of 18.8%[3]. - Methanol sales increased by 8.1% to RMB 870.9 million, with a sales volume increase of 11.0%[3]. - The group's revenue for 2025 is projected to be RMB 671.5 million for urea, RMB 618.2 million for ammonia, and RMB 870.9 million for methanol, reflecting percentage changes of -9.5%, -27.2%, and +8.1% respectively compared to 2024[80]. Assets and Liabilities - Total assets decreased to RMB 4,481 million from RMB 5,414 million in 2024[7]. - Total liabilities decreased to RMB 4,802 million from RMB 5,054 million in 2024[10]. - Current liabilities and total liabilities as of December 31, 2025, were RMB 4,164,060,000 and RMB 320,851,000, respectively[13]. - The company’s total liabilities as of December 31, 2025, were RMB 563,209,000, a decrease from RMB 680,000,000 in 2024, reflecting a reduction of approximately 17.2%[39]. - The group has current liabilities of approximately RMB 4,164,060,000, with short-term borrowings amounting to approximately RMB 2,364,508,000[81]. - The group's capital debt ratio as of December 31, 2025, is approximately 113%, compared to 88% on December 31, 2024[84]. Operational Challenges - The company incurred a significant impairment loss of RMB 287,004,000 on property, plant, and equipment in 2025[26]. - The company has been in litigation that has led to the freezing of certain assets, indicating significant uncertainty regarding its ability to continue as a going concern[13]. - The company is actively negotiating with banks and financial institutions for loan extensions and refinancing[14]. - The group is in discussions with banks and financial institutions for loan extensions and new financing, but no agreements have been reached as of the announcement date[49]. - The group has not reached a clear agreement with bondholders regarding the postponement of principal and interest repayments for the coming year[50]. Cost Management - The cost of goods sold for the year was RMB 2,227,681,000 in 2025, down from RMB 2,565,554,000 in 2024, representing a decrease of approximately 13.2%[27]. - Distribution costs increased by approximately 12.4% compared to the previous year, attributed to inflation, with a distribution cost to sales ratio of 1.31%, up 0.34% from 2024[75]. - Administrative expenses decreased by approximately 16.2% from about RMB 214,200,000 in 2024 to approximately RMB 179,600,000 in 2025, mainly due to the temporary suspension of production at the Guang'an Jiuyuan Electronic Materials Factory and strict cost control[75]. Future Outlook - The company expects to improve cash flow and profitability through the development of certain projects mentioned in the chairman's report[15]. - The group expects certain projects in trial operation to improve liquidity and profitability, but lacks sufficient data to confirm these improvements[50]. - The company plans to enhance internal reforms and innovation to address operational challenges and improve production efficiency[69]. - The company aims to optimize its sales model and increase development efforts for small and medium-sized end customers in the chemical product sector[72]. - The group aims to enhance operational standards and management efficiency, focusing on energy-saving measures and cost reduction to improve business performance[52]. Market Conditions - In 2025, the methanol market saw an increase in production capacity of about 7 million tons, with a total capacity exceeding 110 million tons and an average operating rate of 84%, resulting in a year-on-year production increase of 5.6%[59]. - The methanol market outlook for 2026 anticipates a slight increase in average prices due to geopolitical tensions, with domestic new production capacity expected to be around 3.3 million tons[60]. - The ammonia market experienced a total production capacity of 87.16 million tons, with an average operating rate of 73.16% and a year-on-year production increase of 4.9%[61]. - The ammonia market outlook for 2026 predicts an increase in prices due to geopolitical tensions, with new production capacity expected to be around 500,000 to 600,000 tons[62]. - The urea market in 2025 saw a total production capacity of approximately 78 million tons, with a year-on-year production increase of 4.7% despite a supply surplus leading to price declines[63]. - The urea market outlook for 2026 anticipates price increases due to geopolitical tensions, with new production capacity expected to be around 595,000 tons[64]. Employee and Governance - The group employed 684 employees as of December 31, 2025, a decrease from 773 employees in 2024[90]. - The audit committee has been established since June 10, 2003, and is responsible for reviewing the financial reporting procedures and internal control systems of the company[94]. - The audit committee agrees with management's actions and measures regarding the group's ability to continue as a going concern, with expectations of eliminating the "disclaimer of opinion" in the next financial statements[95].

Market Updates - JD Health (06618) rose over 4.5% following a strategic partnership announcement with leading medical device brand Yuyue Medical [1] - Kangfang Biopharma (09926) increased by over 5.7% after receiving NMPA clinical trial approval for its novel tri-specific antibody drug AK150 for treating advanced malignant solid tumors [1] - Yunfeng Financial (00376) saw a significant rise of 14.18%, with a previous day increase of over 10%, amid a temporary suspension announcement related to a major stock price surge [1] - Steel stocks collectively declined, with Asia Pacific Resources (01104) down 7.59% and Maanshan Iron & Steel (00323) down 7.28% [1] Earnings Warnings and Gains - Jiuyuan Group (00827) fell over 20% after issuing a profit warning, projecting a net loss of approximately RMB 709 million for the year ending December 31, 2025, an increase from a loss of RMB 505 million in 2024 [2] - Changfeng Pharmaceutical (02652) surged nearly 43% after announcing that its inhalation powder ICF001 for treating pulmonary arterial hypertension has received NMPA acceptance for clinical trial application [2] - Yicheng Industrial (01596) rose over 76% after announcing a projected net profit of approximately RMB 334 million for the year ending December 31, 2025, compared to a net loss of RMB 57.7 million in 2024 [3] - Akeso Biopharma (09939) increased by over 10.7% following a strategic cooperation agreement with Funo Pharmaceuticals to develop a new cosmetic product [3] Other Notable Movements - Soundon Technology (02495) rose over 5% after projecting a net profit of no less than RMB 120 million for the year ending December 31, 2025, compared to a net loss of RMB 481 million in 2024 [4] - Starry Chain Group (00399) saw an increase of 18.52% after announcing a memorandum of understanding with Newbridge Acquisition Limited for potential acquisition opportunities [4] US Market Highlights - Tencent Holdings (ADR) (TCEHY.US) rose 1.11% as it welcomed Apple's adjustment of App Store commission policies in China [5] - Meta (META.US) fell 3.83%, marking its largest intraday drop since March 6, due to delays in the release of its new AI model [5] - Ulta Beauty (ULTA.US) dropped 14.24% despite strong same-store sales growth, as fourth-quarter profits fell short of expectations [5] - Bitcoin rose over 5% to $73,764, while Ethereum increased over 6.5% to $2,201.41, reflecting a positive trend in the cryptocurrency sector [6]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈的內容概不負責，對其準確 性或完整性亦不發表任何聲明，並明確表示概不就因本公佈全部或任何部份內容而產生或因 倚賴該等內容而引致的任何損失承擔任何責任。 玖源化工 （集團）有限公司 Ko Yo Chemical (Group) Limited （於開曼群島註冊成立之有限公司） （股份代號：00827） 盈利警告公告 玖源化工(集團)有限公司(「本公司」，連同其附屬公司稱為「本集團」)之董事局(「董事局」) 根據香港聯合交易所有限公司證券上市規則第13.09條及證券及期貨條例（香港法例第571章） 第XIVA部項下的內幕消息條文作出本公佈。 董事局謹此知會本公司股東及有意投資者，根據本集團對截至二零二五年十二月三十一日止 年度之未經審核綜合管理賬目的初步評估，預期於截至二零二五年十二月三十一日止年度， 本集團將錄得本公司權益持有人應佔淨虧損約人民幣 709,000,000 元，相對於截至二零二四年 十二月三十一日止年度之本公司權益持有人應佔淨虧損約人民幣 505,000,000 元，增加虧損約 人民幣 204,000,000 元。二零二五年淨虧損增加之主要原 ...

玖源化工 （集團）有限公司 香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈的內容概不負責，對其準確 性或完整性亦不發表任何聲明，並明確表示概不就因本公佈全部或任何部份內容而產生或因 倚賴該等內容而引致的任何損失承擔任何責任。 玖源化工(集團)有限公司 主席 湯國強 香港，二零二六年三月六日 於本公佈日期，董事會包括三位執行董事，為湯國強先生、張偉華先生及范超先生，及三位 獨立非執行董事徐從才先生、樂宜仁先生及魯藝女士。 Ko Yo Chemical (Group) Limited （於開曼群島註冊成立之有限公司） （股份代號：00827） 董事會會議通告 玖源化工（集團）有限公司（「本公司」，連同其附屬公司統稱「本集團」）之董事會（「董 事會」）謹此公佈，董事將於二零二六年三月三十日上午十時正於香港銅鑼灣告士打道255-257 號信和廣場31樓02室舉行董事會會議，以商討下列事項： 承董事局命 - 1 - 1. 省覽及通過本集團截至二零二五年十二月三十一日止年度之經審核財務報表連同董事 會及核數師報告書，並通過年度業績公佈之刊登； 2. 考慮派發末期股息（如有）； 3. 考慮暫停辦理股份過戶登記手續 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2026年2月28日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 玖源化工(集團)有限公司 呈交日期: 2026年3月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00827 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 20,000,000,000 | HKD | | 0.1 | HKD | | 2,000,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 20,000,000,000 | HKD | | 0.1 | HKD | | 2,000,000,000 | 本月 ...

Key Points - As of February 23, 150 stocks reached a 52-week high, with SH GROWTH RTS (02909), Jiu Yuan Group (00827), and China Urban Infrastructure (02349) leading the high rate at 104.17%, 64.58%, and 46.32% respectively [1] - The top three stocks by closing price that reached new highs are SH GROWTH at 0.105, Jiu Yuan Group at 0.062, and China Urban Infrastructure at 0.167 [1] - Other notable stocks that reached new highs include Li Gao Health Life (02370) at 1.150 with a high rate of 37.65%, and Yabo Technology Holdings (08279) at 0.380 with a 31.67% increase [1] - The report includes a detailed list of stocks that achieved new highs, showcasing their closing prices, highest prices, and the percentage increase from previous levels [1][2][3][4][5]

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2026年1月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 玖源化工(集團)有限公司 呈交日期: 2026年2月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00827 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 20,000,000,000 | HKD | | 0.1 | HKD | | 2,000,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 20,000,000,000 | HKD | | 0.1 | HKD | | 2,000,000,000 | 本月 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示概不就因本公佈全部或任何部份內容而產生或因倚賴 該等內容而引致之任何損失承擔任何責任。 玖 源 化 工（ 集 團 ）有 限 公 司 Ko Yo Chemical (Group) Limited （於開曼群島註冊成立之有限公司） （股份代號：00827） 內幕消息 有關截至二零二四年十二月三十一日止年度年報 持續經營和緩解措施之更新資料 本公佈乃由玖源化工（集團）有限公司（「本公司」，連同其附屬公司統稱「本集 團」）根據香港聯合交易所有限公司證券上市規則（「上市規則」）第13.09條及證 券及期貨條例（香港法例第571章）第XIVA部之內幕消息條文（定義見上市規則）而 作出。 茲提述本公司截至二零二四年十二月三十一日止年度之年報（「年報」）。除本公佈 另有界定者外，本公佈所用詞彙與年報所使用者具有相同涵義。 關於持續經營和緩解措施之更新資料 有關年報中二零二四年十二月三十一日止年度之綜合財務報表附註2及企業管治 常規中「持續經營和緩解措施」一節所披露、二零二五年六月三十日及二零二五年九 月三十 ...